Intercure Ltd.
Produces and distributes GMP-certified, pharmaceutical-grade medical cannabis products.
INCR | TA
Overview
Corporate Details
- ISIN(s):
- IL0011063760
- LEI:
- 549300KI5ESXF8F5GP06
- Country:
- Israel
- Address:
- 11 USSISHKIN STREET, 3844346 HADERA
- Website:
- https://www.intercure.co
- Sector:
- Manufacturing
Description
Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-26 13:42 |
Form 6-ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BEHELD ON DECEMBER 30, 2025
|
English | 501.3 KB | ||
| 2025-11-26 13:42 |
Form 6-ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BEHELD ON DECEMBER 30, 2025
|
English | 104.0 KB | ||
| 2025-11-26 01:03 |
Immediate Report of Meeting
|
English | 501.3 KB | ||
| 2025-11-26 01:03 |
Immediate Report of Meeting
|
English | 100.7 KB | ||
| 2025-11-03 17:02 |
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements …
|
English | 179.2 KB | ||
| 2025-11-03 17:02 |
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements …
|
English | 36.4 KB | ||
| 2025-10-08 20:31 |
Immediate Report
|
English | 322.0 KB | ||
| 2025-10-08 20:31 |
Immediate Report
|
English | 36.5 KB | ||
| 2025-09-19 18:49 |
Immediate Report
|
English | 473.8 KB | ||
| 2025-09-19 18:49 |
Immediate Report
|
English | 36.5 KB | ||
| 2025-05-02 16:15 |
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
|
English | 203.6 KB | ||
| 2025-05-02 16:15 |
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
|
English | 36.2 KB | ||
| 2025-05-01 16:08 |
FORM 20-F
|
English | 1.9 MB | ||
| 2025-05-01 16:08 |
FORM 20-F
|
English | 36.3 KB | ||
| 2025-02-13 09:09 |
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
|
English | 147.7 KB |
Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Intercure Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Intercure Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
